| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.07 | 0.1 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | 0.25 | 0.1 |
| mRNA | CCT007093 | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | Bexarotene | FIMM | pan-cancer | AAC | 0.24 | 0.1 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.1 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.1 |